omada health will prescribe glp-1 drugs starting in 2026. Care Is Leading IPO-Hopeful Health's Latest Growth Surge Everyone's GLP-1 timeline is different.

In studies, GLP-1 and exendin-4 increased nerve growth in dorsal root ganglion neurons but did not affect pain-sensitivity receptors, suggesting a focus on motility [107]

Steatosis and lobular inflammation were scored using the clinical criteria outlined by Kleiner et al

Wang SH, Sun ZL, Guo YJ, Yuan Y, Yang BQ

By measuring changes in these marks, the team could assess whether the treatment was associated with a slower or faster biological aging pattern

Patients initiating GLP-1 therapy for diabetes or weight management who also experience joint pain should maintain a comprehensive approach to musculoskeletal health

Someone in the group accused us of excluding everyone else and the reality is we didntWhen I first read that message, it bothered me, but I was able to let go of it really quickly and kind of not let it affect me. (P2, male, obesity)